Actively Recruiting
Eerder Erbij: The Path Towards Offering Timely Support for People With Dementia and Their Caregivers
Led by VU University of Amsterdam · Updated on 2024-08-15
102
Participants Needed
1
Research Sites
260 weeks
Total Duration
On this page
Sponsors
V
VU University of Amsterdam
Lead Sponsor
Z
ZonMw: The Netherlands Organisation for Health Research and Development
Collaborating Sponsor
AI-Summary
What this Trial Is About
INTRODUCTION AND RATIONALE It has been estimated that at least 50% of the home living persons with dementia in the Netherlands receive little or no formal care and support (Zorgstandaard Dementie, 2013). Reasons why persons with dementia and their informal caregivers receive no formal care vary, include absence of diagnosis, denial of illness, embarrassment or the complexity of the care and referral system. A common concern among health care professionals is that by the time the person with dementia or informal caregiver do seek or receive formal care it may be too late. The difficulties at home may already be so severe that there is little that community-based care can do and admission to residential care may follow soon after. Appropriate support at an earlier stage may prevent more serious difficulties and postpone admission to residential care. Therefore, health care professionals are looking for strategies to reach persons with dementia and caregivers in an earlier stage of dementia and encourage them to accept some form of help or support. The rationale of this study is to investigate how persons living with dementia and their close others can be encouraged to accept support and whether support at an early stage is effective in preventing severe deterioration in wellbeing, behavioural difficulties and high care costs later on. OBJECTIVES * Estimate the effect of EE on caregiver self-efficacy compared to usual care * Estimate the effect of EE on the total care costs of caregiver and person with dementia compared to usual care * Estimate the cost-effectiveness and cost-utility of EE compared to usual care * Perform a process evaluation to monitor delivery of EE and experiences of persons with dementia, caregivers and care professionals * Explore treatment responsiveness of EE in terms of self-efficacy and quality of life STUDY DESIGN Pragmatic, cluster randomised controlled trial. STUDY POPULATION Informal caregivers and people with early-stage dementia, who are community dwelling and receive little or no dementia-related formal ADL care. INTERVENTION The intervention (Eerder Erbij, EE) is a person-centred, manual-based intervention consisting of education, information and a support group. MAIN STUDY PARAMETERS/ENDPOINTS Primary: self-efficacy. Cost-utility: EQ5D, RUD. Secondary: quality-of-life, caregiver burden. DATA COLLECTION Measurements consist of questionnaires (total duration is approximately 1 hour; administered at home; take place at baseline, 3, 6, and 12 months).
CONDITIONS
Official Title
Eerder Erbij: The Path Towards Offering Timely Support for People With Dementia and Their Caregivers
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Informal caregivers can be spouses, relatives, or friends who care for and support the person with dementia without pay
- If the caregiver does not live with the person with dementia, they must visit at least 3 times a week
- The person with dementia must be living at home and cared for by the caregiver
- The person with dementia should have a diagnosis of dementia or severe cognitive impairments suggesting dementia
- The person with dementia is not receiving formal personal care related to daily living activities more than once a week
You will not qualify if you...
- Major mental or physical illnesses affecting participation, such as major depression or stroke, in either the caregiver or person with dementia
- Participation in another intervention or similar support program by either the person with dementia or caregiver
- Dementia caused by HIV, acquired brain impairment, Down syndrome, Huntington's disease, or alcohol abuse
- Inability to give informed consent
- Informal caregiver is younger than 18 years old
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Klinische Neuropsychologie
Amsterdam, North Holland, Netherlands, 1081 BT
Actively Recruiting
Research Team
S
Sanne Balvert, Msc.
CONTACT
M
Maarten Milders, Dr.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here